Elanco Animal Health Incorporated vs Abbvie Inc.
ELAN vs ABBV — side-by-side comparison from reported financials. ELAN leads 2, ABBV leads 8 of 10 comparable metrics.
Elanco Animal Health Incorporated
ELAN · Healthcare
$22.92+1.69%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ELAN | ABBV |
|---|---|---|
| Price | $22.92 | $276.43 |
| Market cap | $11.4B | $488B |
| Revenue (TTM) | $5.02B | $64.4B |
| Revenue growth | +2.3% | +1.8% |
| Net margin | -4.0% | 9.8% |
| Free cash flow | $379M | $18.2B |
| Net cash (debt) | ($3.47B) | ($56.2B) |
| 1-year price return | +14.2% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | 14% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -3% | 96% |
| Altman Z-score | 1.23 | 2.33 |
| CV checks passed | 3 of 9 | 9 of 9 |
| Employees | 9,900 | 57,000 |
Full résumé-style profiles: ELAN CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.